XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Net loss $ (8,111,340) $ (5,711,435)
Depreciation and amortization 17,219 19,102
Loss on debt extinguishment 77,265 3,306,250
Non-cash interest expense 694,836 1,252,689
Legal fees paid through the issuance of convertible debt   63,412
Change in estimated fair value of derivative liabilities 766,903 (6,079,772)
Loss on settlement of convertible note termination 360,186  
Fair market value of equity instruments issued for services, grants and accrued interest 341,547 672,076
Costs associated with issuance of warrants   74,652
Stock based compensation 758,963 1,774,939
Patent license fees paid with issuance of common stock 17,250 17,250
Liquidated damages   149,800
Amortization of debt discount and deferred financing costs 2,598,861 2,027,623
Accounts receivable (400,114)  
Prepaid expenses (1,741) 37,563
Other assets 5,930 (5,588)
Accounts payable and accrued liabilities 920,380 394,801
Due to related parties 112,500 38,305
Net cash used in operating activities (1,841,355) (1,968,333)
Purchases of property and equipment (1,735) (2,541)
Patents and patents pending   (6,805)
Net cash used in investing activities (1,735) (9,346)
Principal repayments of notes payable (223,078)  
Proceeds from the issuance of convertible notes payable 1,694,371 1,105,000
Proceeds from the collection of secured notes receivable 200,000 500,000
Net proceeds from the issuance of common stock 300,000 320,433
Net cash provided by financing activities 1,971,293 1,925,433
Net increase (decrease) in cash 128,203 (52,246)
Cash at beginning of year 15,704 67,950
Cash at end of year 143,907 15,704
Interest 29,645  
Income taxes      
Conversion of debt, accrued liabilities and accrued interest to common stock 2,058,290 1,563,102
Debt discount on notes payable associated with embedded conversion feature and detachable warrants 1,362,082 1,750,540
Reclass of accounts payable to notes payable 124,610  
Recording deferred financing costs associated with convertible notes payable 367,445 254,970
Reclassification of warrant derivative liability into equity 289,124  
Issuance of note receivable in connection with convertible debt financing   $ 400,000